Truven Health Analytics Announces New Solution to Control Outpatient Costs

Truven Health Analytics Announces New Solution to Control Outpatient Costs

For Truven Health AnalyticsJohn Roderick, 631-584-2200

Truven Health Analytics, formerly the Healthcare business of Thomson Reuters, today announced the release of its new Care Comparison Outpatient Executive Reports. The reports help hospitals control spending and improve quality of care by providing critical outpatient data regarding physician utilization, competition within a selected market, and differences in procedure costs.

The reports will be issued to participating hospitals on a quarterly basis and include information that allows administrators to do the following:

“In the current economic climate, hospitals’ ability to control spending while still being able to enhance care is paramount,” said Tim Logan, manager, state associations at Truven Health Analytics. “The information that Care Comparisons Outpatient Executive Reports provides will be integral in the development of outpatient services that promote the best outcomes.”

For more information on the Outpatient Reporting offering, please click .

Truven Health Analytics, formerly the Healthcare business of Thomson Reuters, delivers unbiased information, analytic tools, benchmarks, and services to the healthcare industry. Hospitals, government agencies, employers, health plans, clinicians, pharmaceutical, and medical device companies have relied on us for more than 30 years. We combine our deep clinical, financial, and healthcare management expertise with innovative technology platforms and information assets to make healthcare better by collaborating with our customers to uncover and realize opportunities for improving quality, efficiency, and outcomes. With more than 2,000 employees globally, we have major offices in Ann Arbor, Mich.; Chicago; and Denver. Advantage Suite, Micromedex, ActionOI, MarketScan, and 100 Top Hospitals are registered trademarks or trademarks of Truven Health Analytics. For more information, please visit .